• MK-4827 (Niraparib): Advanced Protocols in Cancer Research

  2026-06-26

  MK-4827 (Niraparib) enables precision DNA damage repair inhibition with robust activity in BRCA-mutant and resistant cancer models. This guide delivers actionable protocols, combinatorial strategies, and expert troubleshooting to help researchers maximize insight from this selective PARP inhibitor.

• Tacrolimus (FK506) in Immune Assays: Scenario-Driven Solutio

  2026-06-25

  This article guides biomedical researchers through common assay challenges—such as reproducibility, protocol optimization, and product selection—using Tacrolimus (FK506) (SKU B2143). Evidence-backed scenarios demonstrate how APExBIO's rigorously formulated FK506 supports sensitive, reliable immune response modulation in cell-based and animal models.

• Ziprasidone HCl as a GOT1 Inhibitor in Pancreatic Cancer Res

  2026-06-25

  The referenced study demonstrates that Ziprasidone HCl, traditionally an antipsychotic, acts as a potent non-competitive GOT1 inhibitor, disrupting glutamine metabolism in pancreatic ductal adenocarcinoma (PDAC) cells. This discovery suggests a new avenue for therapeutic targeting in aggressive pancreatic cancers, with practical utility for researchers studying metabolic reprogramming and tumor proliferation.

• Verbascoside: Precision PKC/NF-κB Inhibition in Bone Researc

  2026-06-24

  Verbascoside is a small-molecule PKC/NF-κB inhibitor with proven efficacy in osteoclastogenesis research. It inhibits PKC activity and NF-κB DNA-binding at micromolar concentrations and is supported by robust cell-based benchmarks. Its solubility profile and storage requirements make it suitable for advanced cell signaling studies.

• Aligned Silk Fibroin–Ce6 Nanofiber Films for Antibacterial P

  2026-06-23

  The reference study introduces an anisotropic silk fibroin film functionalized with Chlorin e6 (Ce6), offering rapid, photodynamically triggered antibacterial activity against S. aureus and facilitating wound healing. This scaffold leverages aligned nanofiber architecture and ROS generation to both eradicate infection and modulate immune repair, advancing the field of antibacterial biomaterials.

• Rotigotine hydrochloride: Reliable Solutions for Neurodegene

  2026-06-23

  This article provides a scenario-driven, evidence-based analysis of Rotigotine hydrochloride (SKU A3777), addressing common laboratory challenges in cell viability and neurodegenerative disease modeling. Drawing on peer-reviewed data and validated protocols, we demonstrate how SKU A3777 delivers reproducibility, workflow safety, and high analytical sensitivity for researchers in Parkinson's disease and dopaminergic signaling studies.

• Açaí Extracts: Effects on Hepatocyte Cytotoxicity and Enzyme

  2026-06-22

  This study rigorously evaluates açaí (Euterpe oleracea) extracts for cytotoxicity and their potential to modulate drug-metabolizing enzymes and transporters in human hepatocytes. The findings clarify that while certain extracts exhibit dose-dependent cytotoxicity, their impact on major CYP enzymes and transporters is minimal, refining risk assessments in botanical-drug interaction research.

• Hypoxic Cognitive Impairment via Choroid Plexus and M1 Macro

  2026-06-22

  This study elucidates how high-altitude hypoxic exposure impairs cognition in mice by disrupting the choroid plexus barrier and promoting M1 macrophage polarization. The work highlights aberrant AMPK signaling and oxidative stress as central drivers, revealing new mechanistic insight for targeting CNS disorders induced by hypoxic stress.

• Dabigatran in Translational Coagulation Research: Beyond Cli

  2026-06-21

  Discover how Dabigatran (Pradaxa) enables advanced, translational coagulation research—from mechanistic insights to protocol innovation. This in-depth analysis bridges clinical pharmacodynamics with bench assay optimization, providing unique strategies for researchers.

• Applied Regorafenib (BAY 73-4506) Workflows in Cancer Biolog

  2026-06-20

  Regorafenib (BAY 73-4506) is redefining angiogenesis and tumor progression studies by enabling precise multikinase inhibition across a spectrum of cancer models. This guide translates recent mechanistic breakthroughs into stepwise experimental protocols, troubleshooting strategies, and practical insights for maximizing research impact.

• DMH1: Precision ALK2 Inhibition for Organoid and NSCLC Resea

  2026-06-19

  DMH1 stands out as a highly selective ALK2 inhibitor, empowering researchers to precisely control BMP signaling in both organoid engineering and non-small cell lung cancer models. Its robust selectivity, reproducible performance, and compatibility with high-throughput workflows make it an indispensable asset for advanced stem cell and cancer biology studies.

• Applied Workflows with PDGF-BB, Murine Recombinant Protein

  2026-06-19

  Leverage murine recombinant PDGF-BB for robust, reproducible cell proliferation assays in smooth muscle and connective tissue research. This guide translates recent metabolic insights and practical troubleshooting into enhanced experimental outcomes for vascular remodeling and pulmonary hypertension studies.

• Dye Models Enhance Small Biopsy Handling in Surgical Patholo

  2026-06-18

  This study systematically evaluated multiple dyes, including alcian blue and hematoxylin, to improve visualization and handling of small tissue biopsies during surgical pathology processing. The findings clarify which dyes aid tissue traceability without interfering with diagnostic staining, informing improved laboratory protocols for challenging small samples.

• Vancomycin Hydrochloride: Applied Workflows in Resistance As

  2026-06-18

  Vancomycin hydrochloride stands as an indispensable glycopeptide antibacterial agent for dissecting antibiotic resistance mechanisms and Gram-positive bacterial susceptibility. This guide provides actionable protocols, troubleshooting insights, and evidence-driven comparisons to maximize its impact in both in vitro and in vivo research.

• Sulfachloropyridazine Modulates Cecal Microbiota in Coccidio

  2026-06-17

  This study systematically evaluates the effects of sulfachlorpyridazine, ethanamizuril, and their combination on the cecal microbial and metabolic landscape in chickens infected with Eimeria tenella. The work provides new insights into drug-specific modulation of gut microbiota and metabolic pathways, informing advanced research strategies for avian coccidiosis.

446 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page